Navigation Links
Study concludes no racial disparities in long-term outcomes in recipients of liver transplants
Date:5/19/2008

CHICAGO (May 19, 2008) New research published in the Journal of the American College of Surgeons shows long-term survival and liver rejection rates are equivalent for African-American liver transplant patients as compared with patients of other races. The study also suggests that although other factors such as liver cancer or hepatitis may negatively influence long-term survival, race does not.

Racial disparities in incidence, severity, methods of treatment and access to care have previously been shown in a variety of diseases, including liver disease. African-American patients appear to be underrepresented among liver transplantation recipients. In 2005, for instance, only 6.8 percent of all patients in the United Network for Organ Sharing database and 9.4 percent of liver transplant recipients were African American, compared with the general population of the United States, in which African Americans represented 12.9 percent of the total.

Survival rates after liver transplantation have been shown to be influenced by race, but earlier data on this subject has been conflicting and may not reflect current management of liver transplant recipients, says Dr. Johnny C. Hong, assistant professor of surgery, Department of Surgery and Liver and Pancreas Transplantation at the University of California, Los Angeles Medical Center in Los Angeles, California. Although our study is the first to find equivalent long-term outcomes among racial groups after liver transplantation, access to care for all patients with end-stage liver disease clearly remains a major goal for all transplant centers. Like many diseases, our patients are best served with early involvement of a multidisciplinary team.

Liver transplantation is required for patients with severe (end-stage) liver disease. People who have liver transplants require close monitoring after their operation and must take drugs that prevent rejection of the transplanted organ (immunosuppressan
'/>"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
Weber Shandwick Worldwide
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study: Doctors Not Always Sure When to Treat Blood Pressure in People With Diabetes
2. JAMA publication features study on depression and head and neck cancer
3. Study: Patients 75 years and older with brain tumors may benefit from more aggressive treatment
4. With age comes a sense of peace and calm, population research center study shows
5. Study: Doctors Significantly Less Likely to Provide Women with Treatments to Prevent Heart Attacks
6. Study finds 21st birthday binge drinking extremely common; can pose serious health hazards
7. Study Finds Gender Disparity in Community-Acquired Pneumonia
8. Cellvizio(R) Confocal Microscopy Improves ERCP Bile Duct Cancer Detection, According to New Study Presented at DDW
9. Not All Colon Cancer Patients Need Chemotherapy: Study
10. Study shows that administering calcium and magnesium effectively reduces neurological sensitivity
11. ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... During 2015-2019, the North American probiotic ... the European and APAC probiotic markets are the dominant ... probiotic market lags behind owing to the certain eating ... North American probiotic market is led by the USA ... and Mexico. The North American market for probiotics is ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 HHT is ... for generations. While it can have seemingly mild ... and catastrophic events. Hereditary Hemorrhagic Telangiectasia (HHT) is ... vessels that lack normal capillary connections between an artery ... cause frequent, severe nosebleeds, but may also be present ...
(Date:5/4/2015)... May 04, 2015 Milton Hershey School® ... 2015 Alumnus of the Year, recognizing his commitment to ... philanthropy he sets for MHS students. , “Dr. Graves ... happen when children are provided a top-notch education, a ... their passions,” said Pete Gurt ’85, president of MHS. ...
(Date:5/4/2015)... 2015 Getting patients to work with ... is critical to achieving the “triple aim” of better ... this will require a shift in thinking from stakeholders ... health systems move beyond their traditional boundaries to reach ... the third live meeting of the ACO and ...
(Date:5/4/2015)... The Lymphoma Research Foundation (LRF) – ... innovative lymphoma research and serving the lymphoma community through ... patient services – is set to host its annual ... West Orange, NJ on June 1, 2015. Since 2010, ... programs through LRF. , This year, the Lymphoma Research ...
Breaking Medicine News(10 mins):Health News:North America Probiotic Market to Increase by 2019, Announces MicroMarketMonitor in Its New Research Report Recently Published at MarketPublishers.com 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 3Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 4Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2
... by Stanford University researchers found patients with refractory partial ... after deep brain stimulation. This multi-center clinical trial ... nuclei of thalamus for epilepsy (SANTE) persisted and by ... frequency. Full findings of this study are available ...
... LEESBURG, Va. , March 17 ... issued a warning to the leadership of the U.S. House ... and pass," "self-executing," or "Slaughter Rule" to enact H.R. 3590, ... been previously approved by the Senate. If this tactic is ...
... to Tackle State,s Health Care Crisis & Everything to Make it Worse , ... , , ... ... BOISE, Idaho , March 17 The health ...
... SAN FRANCISCO , March 17 For the last year, SEIU officials have been suing 29 local union reformers and whistleblowers who exposed the union,s corruption and backroom deals ... ... ... ...
... tends to omit them, report finds , WEDNESDAY, March 17 ... medical studies involving issues of sexual health such as impotence ... "Our study indicates that it,s more prevalent than one might ... which appears in the March 18 issue of the ...
... ... for the first time , ... Las Vegas, NV (Vocus) March 17, 2010, , , , ,Calendar Notice, , ,2011 AHR ... , www.ahrexpo.com , , ,WHAT:    ,2011 AHR EXPO® (International Air-Conditioning, Heating, Refrigerating Exposition) , ...
Cached Medicine News:Health News:Deep brain stimulation reduces epileptic seizures in patients with refractory partial and secondarily generalized seizures 2Health News:Deep brain stimulation reduces epileptic seizures in patients with refractory partial and secondarily generalized seizures 3Health News:Landmark Legal Foundation to File Suit to Stop President's Health Plan if 'Slaughter Rule' is Used 2Health News:Gov. Signs Law Putting Politics Before Patients 2Health News:Gov. Signs Law Putting Politics Before Patients 3Health News:Democracy on Trial: SEIU's $25 Million Lawsuit Against Union Reformers Goes to Court Monday 2Health News:Democracy on Trial: SEIU's $25 Million Lawsuit Against Union Reformers Goes to Court Monday 3Health News:Gays, Lesbians Excluded From Some Medical Studies 2Health News:2011 AHR EXPO Calendar Listing 2Health News:2011 AHR EXPO Calendar Listing 3Health News:2011 AHR EXPO Calendar Listing 4
(Date:5/4/2015)... board of directors of Eli Lilly and Company (NYSE: ... of 2015 of $0.50 per share on outstanding common stock. ... to shareholders of record at the close of business on ... is a global healthcare leader that unites caring with discovery ... were founded more than a century ago by a man ...
(Date:5/4/2015)... and TORONTO , May 4, 2015 ... today announced that it intends to dividend to its ... completion of a definitive licensing agreement to license its ... www.smoofi.com ) (OTCQB:SMFI). As announced on April ... intent in respect of the licensing of its RapidMist™ ...
(Date:5/4/2015)... , May 4, 2015 PharmaEngine, ... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) with ... BAX ) jointly announced that Baxter has submitted ... Medicines Agency (EMA) for MM-398 (irinotecan liposome injection), ... adenocarcinoma of the pancreas who have been previously ...
Breaking Medicine Technology:Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 3Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 4Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 5PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3
... 18, 2012  UCB, a leading biopharmaceutical company committed to ... sponsor multiple sets of key epilepsy data at the ... (AAN) in New Orleans from April 21-28.  The data ... drug (AED) Vimpat® (lacosamide) C-V, including updated health-related quality ...
... 18, 2012  Sotera Wireless, Inc. announced that it has ... Drug Administration (FDA) for the ViSi Mobile™   System, ... in hospitals. The clearance represents a major milestone in ... system, particularly for ambulatory hospital patients. "Continuous ...
Cached Medicine Technology:UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 2UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 3UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 4UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 5UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 6UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 7UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 8UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 9Sotera Wireless Reports FDA Clearance of ViSi Mobile™ System 2
... all Gilson disposable pipette tips, ... sterilized version. Each Sterilized TowerPack ... device-quality plastic to help protect ... guaranteed by the red sticker, ...
Designed to fit a variety of 250 L and 300 ul multi-channel pipettors, this tip offers a secure fit and extra space for repeat pipetting....
... Aerosol barrier tips eliminate false ... Scientifically designed and tested, Promega Barrier ... working with amplified nucleic acids (PCR(a)), ... samples, forensic and serological specimens. , ...
Inquire...
Medicine Products: